» Articles » PMID: 26579714

Investigating DNA Binding and Conformational Variation in Temperature Sensitive P53 Cancer Mutants Using QM-MM Simulations

Overview
Journal PLoS One
Date 2015 Nov 19
PMID 26579714
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The tp53 gene is found to be mutated in 50% of all the cancers. The p53 protein, a product of tp53 gene, is a multi-domain protein. It consists of a core DNA binding domain (DBD) which is responsible for its binding and transcription of downstream target genes. The mutations in p53 protein are responsible for creating cancerous conditions and are found to be occurring at a high frequency in the DBD region of p53. Some of these mutations are also known to be temperature sensitive (ts) in nature. They are known to exhibit partial or strong binding with DNA in the temperature range (298-306 K). Whereas, at 310 K and above they show complete loss in binding. We have analyzed the changes in binding and conformational behavior at 300 K and 310 K for three of the ts-mutants viz., V143A, R249S and R175H. QM-MM simulations have been performed on the wild type and the above mentioned ts-mutants for 30 ns each. The optimal estimate of free energy of binding for a particular number of interface hydrogen bonds was calculated using the maximum likelihood method as described by Chodera et. al (2007). This parameter has been observed to be able to mimic the binding affinity of the p53 ts-mutants at 300 K and 310 K. Thus the correlation between MM-GBSA free energy of binding and hydrogen bonds formed by the interface residues between p53 and DNA has revealed the temperature dependent nature of these mutants. The role of main chain dihedrals was obtained by performing dihedral principal component analysis (PCA). This analysis, suggests that the conformational variations in the main chain dihedrals (ϕ and ψ) of the p53 ts-mutants may have caused reduction in the overall stability of the protein. The solvent exposure of the side chains of the interface residues were found to hamper the binding of the p53 to the DNA. Solvent Accessible Surface Area (SASA) also proved to be a crucial property in distinguishing the conformers obtained at 300 K and 310 K for the three ts-mutants from the wild type at 300 K.

Citing Articles

Toward Cancer Diagnostics of the Tumor Suppressor p53 by Surface Enhanced Raman Spectroscopy.

Bizzarri A, Cannistraro S Sensors (Basel). 2020; 20(24).

PMID: 33327383 PMC: 7764831. DOI: 10.3390/s20247153.


Investigation of a Direct Interaction between miR4749 and the Tumor Suppressor p53 by Fluorescence, FRET and Molecular Modeling.

Bizzarri A, Cannistraro S Biomolecules. 2020; 10(2).

PMID: 32098369 PMC: 7072324. DOI: 10.3390/biom10020346.


Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting.

Sing Tan Y, Mhoumadi Y, Verma C J Mol Cell Biol. 2019; 11(4):306-316.

PMID: 30726928 PMC: 6487789. DOI: 10.1093/jmcb/mjz009.


P53 and Murine Double Mimute 2 (MDM2) Expression Changes and Significance in Different Types of Endometrial Lesions.

Jiang Z, Xu W, Dan G, Liu Y, Xiong J Med Sci Monit. 2016; 22:4786-4793.

PMID: 27924072 PMC: 5158131. DOI: 10.12659/msm.898616.

References
1.
Cheok C, Verma C, Baselga J, Lane D . Translating p53 into the clinic. Nat Rev Clin Oncol. 2010; 8(1):25-37. DOI: 10.1038/nrclinonc.2010.174. View

2.
Greenblatt M, BENNETT W, Hollstein M, Harris C . Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54(18):4855-78. View

3.
Wong K, DeDecker B, Freund S, Proctor M, Bycroft M, Fersht A . Hot-spot mutants of p53 core domain evince characteristic local structural changes. Proc Natl Acad Sci U S A. 1999; 96(15):8438-42. PMC: 17534. DOI: 10.1073/pnas.96.15.8438. View

4.
Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon L . Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations. J Mol Biol. 2008; 385(1):249-65. DOI: 10.1016/j.jmb.2008.10.063. View

5.
Cho Y, Gorina S, Jeffrey P, Pavletich N . Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994; 265(5170):346-55. DOI: 10.1126/science.8023157. View